TNFα kinoid vaccination-induced neutralizing antibodies to TNFα protect mice from autologous TNFα-driven chronic and acute inflammation
暂无分享,去创建一个
Marie-Christophe Boissier | R. Gallo | D. Zagury | Hélène Le Buanec | Laure Delavallée | Natacha Bessis | Sébastien Paturance | Bernard Bizzini | Robert Gallo | Daniel Zagury | B. Bizzini | N. Bessis | M. Boissier | H. Le Buanec | L. Delavallée | S. Paturance
[1] L. Klareskog,et al. Rheumatoid arthritis and malignant lymphomas , 2004, Current opinion in rheumatology.
[2] B. Scallon,et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. , 1993, Molecular immunology.
[3] C. Galanos,et al. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.
[4] L. V. D. van de Putte,et al. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis. , 2002, The Journal of rheumatology.
[5] U. Chaudhari,et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial , 2001, The Lancet.
[6] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[7] J. Cavaillon,et al. Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. , 2004, Vaccine.
[8] D. Hommes,et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). , 1995, Gastroenterology.
[9] R. Karlsson,et al. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.
[10] J. Woody,et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.
[11] D. Shealy,et al. Anti-TNF-α antibody allows healing of joint damage in polyarthritic transgenic mice , 2002, Arthritis research.
[12] J. Salfeld. Use of new biotechnology to design rational drugs against newly defined targets. , 2004, Best practice & research. Clinical rheumatology.
[13] G. Kollias,et al. Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study , 2004, Arthritis research & therapy.
[14] P. Anderson. Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles. , 2005, Seminars in arthritis and rheumatism.
[15] X. le Loët,et al. Rheumatoid arthritis in 2005: which patients should receive TNFalpha antagonists and when? A point of view. , 2005, Joint, bone, spine : revue du rhumatisme.
[16] C. Bisbal,et al. The 2–5A/RNase L/RNase L Inhibitor (RNI) Pathway Regulates Mitochondrial mRNAs Stability in Interferon α-treated H9 Cells* , 2001, The Journal of Biological Chemistry.
[17] S. Youssef,et al. A Targeted DNA Vaccine Augments the Natural Immune Response to Self TNF-α and Suppresses Ongoing Adjuvant Arthritis1 , 2000, The Journal of Immunology.
[18] R. Day. Adverse reactions to TNF-α inhibitors in rheumatoid arthritis , 2002, The Lancet.
[19] D. Scherman,et al. Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. , 2004, Human gene therapy.
[20] D. Gray,et al. T cell memory is short-lived in the absence of antigen , 1988, Nature.
[21] M. Feldmann,et al. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] Petra Lenz,et al. Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles , 2002, The Journal of Immunology.
[23] A. Herbelin,et al. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL‐10‐dependent pathway , 2005, European journal of immunology.
[24] M. Feldmann,et al. Therapeutic antibodies elicited by immunization against TNF-α , 1999, Nature Biotechnology.
[25] A. Mantovani,et al. The type II decoy receptor of IL‐1 inhibits murine collagen‐induced arthritis , 2000, European journal of immunology.
[26] J. Renauld,et al. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Lowy,et al. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. , 2001, The Journal of clinical investigation.
[28] M. Feldmann,et al. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases , 2003, Nature Medicine.
[29] M. Feldmann,et al. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. , 2000, Arthritis and rheumatism.
[30] A. Achour,et al. "Kinoids": the basis for anticytokine immunization and their use in HIV infection. , 1995, Cellular and molecular biology.
[31] A. Burny,et al. Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. , 2003, Cytokine & growth factor reviews.
[32] A. Burny,et al. Toward a new generation of vaccines: The anti-cytokine therapeutic vaccines , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] L. Steinman,et al. Design of effective immunotherapy for human autoimmunity , 2005, Nature.
[34] A. Corrado,et al. TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis , 2004 .
[35] D. Hommes,et al. Targeting tumor necrosis factor‐&agr; in inflammatory bowel disease: why, how, and when? , 2003, Current opinion in gastroenterology.
[36] D. Kioussis,et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.